Characteristics of subjects reporting beta-agonist use at baseline by race and <b><i>ADRB2</i></b><b> Arg16Gly genotype</b>
收藏NIAID Data Ecosystem2026-03-06 收录
数据链接：
官方服务：
资源简介：
*GOLD Stage II obstructive lung disease defined as percent-predicted FEV1<80% and FEV1/FVC<70% based on criteria from the Global Initiative for Chronic Obstructive Lung Disease [26] †p<0.05 for test of difference across genotype using χ2 test of heterogeneity for Rx2 contingency table for categorical variables or ANOVA F test for continuous variables, transformed as needed
创建时间：
2007-03-14
